chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the shot at 10:00AM. Around 1:00PM I was feeling like I had no energy. I went to sleep at 9:30PM. Woke up at 11:30PM extremely cold and shaking, no fever. Was awake for about 45 minutes then slept for about an hour. Woke up again insanely hot and sweaty. Then I kept waking up every 30-60 minutes. Woke up for the day at 6:05AM. Had a headache, very bad body aches, brain fog, dizzy, fever, no energy. Spent the whole day feeling like this. Woke up the next morning at 6:05AM, still had a lot of body aches and a low fever. Also now had chest pains. It is now 11:30 PM and I do not have a fever but still have body aches and chest pains.
Patient got nausea and threw up  10 minutes after getting the vaccine. She also complained of hot flashes and dizziness. She said she just had some food before coming for the vaccination. Paramedics were called in and they checked her vitals. Her vitals were fine They stabilized her and she was able to go home on her own.
Pt called complained of silver dollar sized raised, red and itchy area on right arm about 4 hours after injection.  24 hours after injection, complained of diffuse rash on fatty areas of body, including itching, redness.
After about 4 hours after the vaccine was administered, patient's arm swelled up and was swelling and hurting until 2-3 AM that night. Patient woke up and had hives all over body and was itchy. Body turned red and had small bumps. Patient took benadryl and symptoms cleared up. Hives would come back periodically and patient would take more benadryl every 6 to 8 hours. Patient went to his Dr's office and they prescribed him cetirizine with hydroxyzine. Symptoms resolved after a couple of hours.
I experienced Covid Arm 7 days after my shot, as it became known to me after I looked up my symptoms and talked with my doctor. Started with itching at injection site, which became very warm. After about an hour or so I noticed it was very sore and swollen. It developed a red circle around it on the second day, and was at least 2 inches in diameter. It was hard, hot and itchy. Probably due to the swelling, my arm became sore from shoulder down through my hand for about 24 hours. Two days later the swelling began to go down, the heat went away, and I?d say the itching mostly subsided within the 48 hours since it started. All normal now!
Starting at 1100, (21 hours after vaccination) patient was brushing his teeth and noticed water was just drooling out of his mouth and when he looked in the mirror one side of his face didn't move, he thought he suffered a CVA
PT REC'D DOSE 4/21/22, IMMUIZATION REGISTRY SHOWED THIS AS PPSV (THOUGH IT WAS PNEUMOVAX) GAVE ANOTHER DOSE 6/20/23
inj site rt arm painful w/swelling surrounded by 5-6cm area of induration;where inj was given 23OCT97;pt seen by MD & instructed to make appointment w/pvt MD for tx;
16 Yr old patient was given a Moderna COVID-19 Vaccine as off-label use
Started to develop red, itchy rash on left side of neck a few hours after the injection.  By the next day rash had spread to left shoulder and chest.  I received the injection in left upper arm.  I have not administered any type of treatment to the rash at this point.
Persistent chest pain. The chest pain is felt throughout the day and tends to increase during the evening. It continues today, 4 months after receiving the vaccine.   Additionally, 3 days after receiving the vaccine I lost hearing in my left ear. Hearing returned on day 4.
Patient given higher dose of vaccine due to vaccine not properly diluted. Pfizer vaccine kids 5 to 11 not diluted before being administered to the patient. As a result patient received 30mcg of Pfizer vaccine instead of 10mcg dose.
Covid Dx: July 2020,.  Post initial vaccine, fever, chills, exhaustion for the first 27 hours.   Night sweats days 2 and 3.  Low grade fever tends to be persistent at night time.  Day 3 and Day 4, increased GI symptoms with nausea.  Ibuprofen has been used to control symptoms and discomfort.
right eye went blind for several Minutes; hemorrhage behind eye; when it cleared I had white clouds that were blocking vision; PAMM; This is a spontaneous report from a contactable consumer. A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, in the left (unspecified anatomical location) on 12Apr2021 (Batch/Lot Number: ER8734), at the age of 61-years-old, as single dose for COVID-19 immunization. Medical history included overweight and elevated BP. The patient own allergies. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration in the left arm on 22Mar2021 02:30 pm (lot number: EP7534), at the age of 61-years-old. There are other unspecified medications in the last two weeks. There are no other vaccines in four weeks. The patient experienced right eye went blind for several minutes and when it cleared, the patient had white clouds that were blocking vision. Ophthalmologist saw hemorrhage behind eye called it PAMM. The events happened 4 hours after vaccine 2nd dose on 12Apr2021 18:00. Retinal specialist believed it may be vascular but could not determine cause. Dr. advised that he was one of several patients who had eye issues after vaccine. Therapeutic measures were taken as a result of the events. The patient had no prior vaccination, the patient was not tested for COVID post vaccination. The outcome of the event was not recovered. The events were reported as serious- disability.
Moderna was given to a 16 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 034CA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old). On 14-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna was given to a 16 year old) had resolved. Not applicable      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported.   No treatment drugs were reported.   This case was linked to MOD-2021-256223 (Patient Link).
local rxn of redness 3 1/2 x 2 1/2;
This spontaneous report as received from an office manager (medical assistant) refers to unknown number of patients. On unknown dates the patients might have received improperly stored GARDASIL. The vaccine was exposed to temperatures of 32F for 32 minutes on 02-DEC-2013, then 32F for 24 minutes on 03-DEC-2013, then on the same day 03-DEC-2013 at 31F for 8 minutes, then 33F for 19 minutes on 04-DEC-2013, then 33F for 34 minutes on 17-DEC-2013. No adverse effects reported. This is one of four reports received from the same reporter. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient presents to clinic three days after vaccination reporting pain and swelling in left lower leg starting shortly after receiving vaccine. Vital signs all within normal ranges. Physical exam shows asymetrical left lower leg edema with pitting edema 2+ to the level of knee. Both knees have decreased range of motion and effusion (during visit underwent bilateral knee arthrocentesis). Normal pulmonary effort and no respiratory distress. Patient diagnosed with deep vein thrombosis (DVT) and started on anticoagulation.
Developed fever, malaise & diffuse rash on day 3-4 after shot.
They have had Covid twice, the first time in Jan2021 and the second time on 24Aug2022.; They have had Covid twice, the first time in Jan2021 and the second time on 24Aug2022.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 24Aug2022, outcome "unknown" and all described as "They have had Covid twice, the first time in Jan2021 and the second time on 24Aug2022.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2021) positive, notes: first time in Jan2021; (24Aug2022) positive, notes: the second time on 24Aug2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The caller thanked Pfizer for the vaccinations and said her and her husband have taken them all, up to the first booster. They can't take the second booster until 3 months after the Covid from August. The caller stated, they had Covid twice, the first time in Jan2021 and the second time on 24Aug2022. She and her husband took Paxlovid and took all of it, 3 in morning and 3 in "afternoon" after their meal. She stated there is not any age limit from age 16 to 90 and this confused her and then there is nothing for weight and size. She stated, she is taking the same pill as her husband who is almost 70 years old, 6 ft and almost 200 pounds.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
painful arm; headache; sore arm; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (painful arm), HEADACHE (headache) and MYALGIA (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm). On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (painful arm) and HEADACHE (headache). On 15-Jan-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm) had resolved. At the time of the report, PAIN IN EXTREMITY (painful arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
This started with tiredness, sore throat slight fever lasting 4-5 days. Rapid test on the cruise ship. Positive.
Arm is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in left arm, administration date 03Mar2021 at 17:30 (Lot number: EL3248) at the age of 44 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATORVASTATIN; VITAMIN D [COLECALCIFEROL]; METAMUCIL REGULAR; FISH OIL. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 04Mar2021, outcome "recovered" (06Mar2021), described as "Arm is sore". Therapeutic measures were not taken as a result of pain in extremity. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
little bit of weird pain on his arm pit; This is a spontaneous report received from a contactable consumer (Patient). A male patient of an unspecified age received BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, (Batch/Lot number was not reported, Solution for injection), via an unspecified route of administration on 24May2021 as unknown, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced little bit of weird pain on his arm pit. He was vaccinated on 24May2021, and he still had a little bit of a weird pain on his arm pit. His kids and wife were feeling better, he wanted to know how long this will last. The outcome was not recovered. Information on the lot/batch number has been requested.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 12-MAY-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
first dose of  shingrix 3 years ago (elsewhere), 2nd shot on Nov 2020, about 2.5 years apart; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 85-year-old female patient who received Herpes zoster (Shingrix) (batch number 22LC7, expiry date 27th August 2022) for prophylaxis.   Previously administered products included shingrix (1st dose received 3 years ago from day of reporting).   In November 2020, the patient received the 2nd dose of Shingrix. In November 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were reported as follows: The patient received the 2nd dose of Shingrix later than the recommended schedule, which led to lengthening of vaccination schedule. The patient received 2nd dose about 2.5 years apart from 1st dose. The reporter asked did the dose need to be repeated or not. The reporter did not consent to follow-up.
Presented with cough, shortness breath, malaise.  Tested positive for COVID19 outpatient, was started on Z-Pak and steroids by her PCP with no improvement in symptoms.  She presented to the ER, found to be hypoxic, chest x-ray showed patchy infiltrates, COVID19 positive. Tx w/steroids, remdesivir, O2, zinc; weaned off O2 for DC home.
I woke up today with an unusual headache very early.  Around 2 hours later when I went to take a shower, I noticed an unusual, splotchy rash on my left knee.  I have CRPS in this limb and initially assumed it had something to do with that, but once I inquired in my support group I was shown pictures and articles of rashes much like mine as a sign of CRPS.  I have had a stuffy nose since before my vaccine and it was just that (had a negative covid test).  I schedule a test for 12:51 today.
Severe headache starting with 2 hours post injection lasting 6 days, severe nausea 6 days, diarrhea day 3 only.  Red circular spot on hand, toes, shoulder area, day 2-4.
Patient's father at reported an incorrect date of birth for his child in order to get the vaccine.  The patient age was 4 years and 11 months.  I did not require any identification for children receiving the recently approved Pfizer vaccine at the time.  I was going by the honor system.  I found out when I billed the insurance and it rejected on the basis of the child not being old enough.  No adverse event occured as the result of this incident.
This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainting reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (Fainting reaction) (seriousness criterion medically significant). At the time of the report, SYNCOPE (Fainting reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced COVID-19 (Tested positive for covid). At the time of the report, COVID-19 (Tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was provided.   Reporter did not allow further contact
Pronounced pain 5h after vaccine, followed by increased pain and severe swelling of arm over next 24h. Patient went to ER diagnosed with cellulitis in the arm and admitted to hospital I.V. antibiotics administered during 1 day stay. Patient had to return for outpatient I.V. antibiotics additional 7 days.
Onset mid August 2021 6 months after civid 2 jab series, of typical right face/cheek trigeminal neuralgia  without dental or sinus etiology  persisting now 3 weeks nearly daily with textbook characteristics of shooting lancinating shooting facial pain triggered by lightly touching malar zygoma sea of right cheek.  Lasts. Few minutes area is sensitive but not tender.
Fever over 103, violent shaking, headache, nausea, extreme fatigue and muscle pain
Day 12 after vaccine, started having chest tightness. Awaken on day 14 to shortness of breath, fatigue, sweating, excessive chest pain. This continued for 6 days and I called my internal medicine doctor, Doctor. She got me in on day 7 of symptoms increasingly more intense daily. She ordered chest x-ray, prescribed amoxicillin and albuterol inhaler. Day 8 chest x-ray results came back with small mass lung lower lobe, Dr. ordered a CT scan. Symptoms only increased with medicine. On day 10 had CT scan that showed Mass to be prior Scar Tissue possibly. Annual CT scan ordered for follow up. Also in CT scan of lungs, some bronchial inflammation. Doctor called me and we spoke of vaccine and she was unsure if it was that or some other exposure but upon my insistence, she called in a Breo steroid inhaler and prednisone 10-day regimen. I still had no relief oh, I only felt worth shortness of breath, bronchial and lung pain and chest tightness so I called back a few days later. I beg for something to be done and she called in a z-pack and gave me a referral to a lung specialist in case this was related to vaccine because she did not know what else to do. Because of backlog at lung specialist, I am waiting for four more weeks for an answer. However, I don't feel any better at all today, September 24th. I have had symptoms for over 5 weeks with no relief. It has now been nearly 60 days since vaccine. I never left house after vaccine and my husband never felt sick. Therefore, I do not believe this is anything other than an adverse reaction from the Johnson vaccine. I do not smoke, have not smoked, never had lung issues before.
Within 2 minutes of the vaccination, the patient became unresponsive and seized, also exhibiting some facial redness and sweating. Within a minute of that reaction, the patient was alert and oriented x4. He noted that he felt dizzy but was not aware of the events that had transpired.
Acquired COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Acquired COVID-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Acquired COVID-19). At the time of the report, COVID-19 (Acquired COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
left arm is sore; got terribly ill; projectile vomiting; My head is, of course, hurting; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got terribly ill), VOMITING (projectile vomiting), HEADACHE (My head is, of course, hurting) and VACCINATION SITE PAIN (left arm is sore) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 011M20A) for COVID-19 vaccination.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPRIN) for Headache.    The patient's past medical history included No adverse event.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ACETYLSALICYLIC ACID (ASPRIN) (unknown route) at an unspecified dose. On 11-Feb-2021, the patient experienced ILLNESS (got terribly ill), VOMITING (projectile vomiting) and HEADACHE (My head is, of course, hurting). On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (left arm is sore). At the time of the report, ILLNESS (got terribly ill), VOMITING (projectile vomiting), HEADACHE (My head is, of course, hurting) and VACCINATION SITE PAIN (left arm is sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided
It started around 11:12 PM and it really hit me hard. I was not able to sleep the whole night it is currently 4 PM the next day and I?m still experiencing the exact same symptoms as what I was last night which is chills causing me to sweat through T-shirts unable to sleep, extreme discomfort, my arm hurts at the injection site, but the main issue is the body aches, extreme headache,Extreme nauseousness to the point where I feel like I need to throw up but I cannot and all around flu like symptoms. AlthoughI feel as though I have a fever I have checked it a few times and I do not. It has not let up at all since last night I am only able to sleep in 30 to an hour increments